Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

Kerr, K.M.; Bubendorf, L.; Edelman, M.J.; Marchetti, A.; Mok, T.; Novello, S.; O'Byrne, K.; Stahel, R.; Peters, S.; Felip, E.

doi:10.1093/annonc/mdu145

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

Details

Request a copy

Serval ID

serval:BIB_752C25820E8A

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

Journal

Annals of Oncology

Author(s)

Kerr K.M., Bubendorf L., Edelman M.J., Marchetti A., Mok T., Novello S., O'Byrne K., Stahel R., Peters S., Felip E.

Working group(s)

Panel Members, Panel Members

Contributor(s)

Stahel R., Felip E., Peters S., Kerr K., Besse B., Vansteenkiste J., Eberhardt W., Edelman M., Mok T., O'Byrne K., Novello S., Bubendorf L., Marchetti A., Baas P., Reck M., Syrigos K., Paz-Ares L., Smit EF., Meldgaard P., Adjei A., Nicolson M., Crinò L., Van Schil P., Senan S., Faivre-Finn C., Rocco G., Veronesi G., Douillard JY., Lim E., Dooms C., Weder W., De Ruysscher D., Le Pechoux C., De Leyn P., Westeel V.

ISSN

1569-8041 (Electronic)

ISSN-L

0923-7534

Publication state

Published

Issued date

2014

Peer-reviewed

Oui

Volume

Number

Pages

1681-1690

Language

english

Notes

Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish

Abstract

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The Second ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on management of patients with non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, early stage disease, locally advanced disease and advanced (metastatic) disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on recommendations for pathology and molecular biomarkers in relation to the diagnosis of lung cancer, primarily non-small-cell carcinomas.

OAI-PMH

oai:serval.unil.ch:BIB_752C25820E8A

DOI

10.1093/annonc/mdu145

Pubmed

24718890

Web of science

000342353600003

Open Access

Yes

Create date

20/10/2014 8:33